SCHEMBL6395773

SCHEMBL6395773

Cn1c(=O)[nH]c(=O)c2cccc(S(=O)(=O)O)c21

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 2/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ TTR P02766 1/20 0.39
▸ FEN1 P39748 7/20 0.36
▸ PDE3A Q14432 1/20 0.35
▸ PARG Q86W56 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MYC P01106 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ KEAP1 Q14145 1/20 0.34
▸ NFE2L2 Q16236 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6392722 0.82 TTR (0.37) TTRFEN1MYCCYP1A2
SCHEMBL6394628 0.82 ADORA2A (0.44) ADORA2BADORA3ADORA2AADORA1PDE3A
SCHEMBL6390848 0.81 POLB (0.38) TTRFEN1CYP1A2
SCHEMBL6388595 0.81 CYP1A2 (0.42) ADORA2BADORA2ATTRFEN1MEN1
SCHEMBL6388179 0.81 MEN1 (0.35) ADORA2BADORA3ADORA2AADORA1PDE3A
SCHEMBL6389576 0.80 CNR1 (0.42) ADORA2BADORA2AMEN1KMT2ABRD4
SCHEMBL6389551 0.79 FEN1 (0.50) ADORA2BADORA3ADORA2AADORA1FEN1
SCHEMBL6388310 0.78 MAT2A (0.41) FEN1LMNAMEN1USP2KMT2A
SCHEMBL6389536 0.78 SMN1; SMN2 (0.40) FEN1LMNAMEN1KMT2ACYP1A2
SCHEMBL6393958 0.78 PARG (0.34) ADORA2BFEN1PDE3APARGLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1237119-C Dopant agent and electroconductive polymer materials comprising the same MITSUI CHEMICALS INC (JP) 2006-01-18 — — CN disclosed
US-20050040373-A1 Dopant and conductive polymer material therewith MITSUI CHEMICALS, INC. (JP) 2005-02-24 — — US disclosed
US-6814888-B2 FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR MITSUI CHEMICALS, INC. (JP) 2004-11-09 — — US disclosed
CN-1462299-A Dopant agent and electroconductive polymer materials comprising the same MITSUI CHEMICALS INC (JP) 2003-12-17 — — CN disclosed
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same MITSUI CHEMICALS, INC. (JP) 2003-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same RPS6, H1-10, H1-0 ADORA2B 2241/4885ADORA3 1818/4885ADORA2A 2296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback